LIDDS
0.155 SEK +19.23%1 investor is following this company
LIDDS is a pharmaceutical company. The company develops pharmaceutical products based on a patent-protected and clinically tested drug delivery technology. The properties of the products form the basis of LIDDS 'technology platform for the development of injectable drug products. LIDDS is the abbreviation for Local Intelligent Drug Delivery System and the company is headquartered in Uppsala.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
LIDDS
Daily low / high price
0.12 / 0.155
SEK
Market cap
21.15M SEK
Turnover
5.49K SEK
Volume
44K
Financial calendar
Interim report
2024-08-28
Interim report
2024-11-21
Annual report
2025-02-20
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 13.4 % | 13.4 % |
Wikow Venture | 6.1 % | 6.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
LIDDS AB (publ) Interim Report January – March 2024
Stämmokommuniké från årsstämma i LIDDS AB (PUBL) den 27 maj 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools